Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
12 November 2021 - 11:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE
ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF
1934
For the month of November 2021
Commission File Number: 001-39137
AnPac Bio-Medical Science
Co., Ltd.
(Registrant’s name)
801 Bixing Street, Bihu County
Lishui, Zhejiang Province
323006
The People’s Republic
of China
(Address of principal executive
office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F x Form 40-F ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (1): ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (7): ¨
Explanatory Note:
The document attached as exhibit
1.1 to this Form 6-K is hereby incorporated by reference into the Registrant’s Registration Statement on Form F-3 initially filed
with the U.S. Securities and Exchange Commission on May 28, 2021 (Registration No. 333-256630) and shall be a part thereof from the date
on which this current report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.
Attached as exhibits to this
Report on Form 6-K are:
|
|
(1)
|
the Underwriting Agreement dated November 9, 2021 as Exhibit 1.1;
|
|
|
(2)
|
the press release dated November 9, 2021; and
|
|
|
(3)
|
the corrective press release dated November 11, 2021.
|
Exhibit Index:
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
|
|
AnPac Bio-Medical Science Co., Ltd.
|
|
|
|
(Registrant)
|
|
|
|
|
|
Date: November 12, 2021
|
By:
|
/s/ Chris Chang Yu
|
|
|
Name:
|
Dr. Chris Chang Yu
|
|
|
Title:
|
Chairman of the Board of Directors and Chief Executive Officer
|
AnPac Bio Medical Science (NASDAQ:ANPC)
Historical Stock Chart
From Mar 2024 to Apr 2024
AnPac Bio Medical Science (NASDAQ:ANPC)
Historical Stock Chart
From Apr 2023 to Apr 2024
